Ehrlich Financial Group
- SEC CIK
- 0002010632
- Latest filing
- Jul 9, 2026
EW holding history
Edwards Lifesciences Corp in every 13F filed by Ehrlich Financial Group, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
EW overviewAll 13F holders of EWFull Q2 2026 holdings
- Shares (Q2 2026)
- 7,640
- Value
- $691.2K
- % of portfolio
- 0.4%
- Quarters held
- 11
- Since Q4 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 7,640 | $691.2K | 0.4% | 00.0% | Unchanged | Holders |
| Q1 2026 | 7,640 | $611.9K | 0.4% | −656−7.9% | Reduced | Holders |
| Q4 2025 | 8,296 | $707.2K | 0.4% | −2,959−26.3% | Reduced | Holders |
| Q3 2025 | 11,255 | $875.3K | 0.5% | +57+0.5% | Added | Holders |
| Q2 2025 | 11,198 | $875.8K | 0.6% | +248+2.3% | Added | Holders |
| Q1 2025 | 10,950 | $793.6K | 0.6% | +586+5.7% | Added | Holders |
| Q4 2024 | 10,364 | $767.2K | 0.5% | −140−1.3% | Reduced | Holders |
| Q3 2024 | 10,504 | $693.1K | 0.5% | +220+2.1% | Added | Holders |
| Q2 2024 | 10,284 | $949.9K | 0.7% | +3,556+52.9% | Added | Holders |
| Q1 2024 | 6,728 | $642.9K | 0.5% | +2,591+62.6% | Added | Holders |
| Q4 2023 | 4,137 | $315.4K | 0.3% | – | No prior filing | Holders |